Publications
- Dunne J, Dutz J, Shojania K, Ng B, van Eeden S. Treatment of severe Raynaud's phenomenon with bosentan in a patient with systemic sclerosis. Rheumatology (Oxford). 2006 Jul;45(7):911-2. Epub 2006 Mar 10. PMID: 16531439 [PubMed - indexed for MEDLINE]
- Ghoreishi M, Dutz JP. Tolerance induction by transcutaneous immunization through ultraviolet-irradiated skin is transferable through CD4+CD25+ T regulatory cells and is dependent on host-derived IL-10. J Immunol. 2006 Feb 15;176(4):2635-44. PMID: 16456026 [PubMed - indexed for MEDLINE]
- O'Brien BA, Geng X, Orteu CH, Huang Y, Ghoreishi M, Zhang Y, Bush JA, Li G, Finegood DT, Dutz JP. A deficiency in the in vivo clearance of apoptotic cells is a feature of the NOD mouse. J Autoimmun. 2006 Mar;26(2):104-15. Epub 2006 Jan 20. PMID: 16431079 [PubMed - indexed for MEDLINE]
- Oble DA, Collett E, Hsieh M, Ambjorn M, Law J, Dutz J, Teh HS.
A novel T cell receptor transgenic animal model of seborrheic dermatitis-like
skin disease.
J Invest Dermatol. 2005 Jan;124(1):151-9.
- Schutze-Redelmeier MP, Kong S, Bally MB, Dutz JP.
Antennapedia transduction sequence promotes anti tumour immunity to epicutaneously administered CTL epitopes.
Vaccine. 2004 May 7;22(15-16):1985-91.
- Klimuk SK, Najar HM, Semple SC, Aslanian S, Dutz JP.
Epicutaneous application of CpG oligodeoxynucleotides with peptide or protein antigen promotes the generation of CTL.
J Invest Dermatol. 2004 Apr;122(4):1042-9.
- Kahlon R, Dutz JP. Skin immune responses to peptide and protein antigen are TLR4 independent.
Cell Immunol. 2003 Dec;226(2):116-23.
- Kahlon R, Hu Y, Orteu CH, Kifayet A, Trudeau JD, Tan R, Dutz JP.
Optimization of epicutaneous immunization for the induction of CTL.
Vaccine. 2003 Jun 20;21(21-22):2890-9.
- Zhang Y, O'Brien B, Trudeau J, Tan R, Santamaria P, Dutz JP. In situ beta cell death promotes priming of diabetogenic CD8 T lymphocytes.
J Immunol. 2002 Feb 1;168(3):1466-72.
|
« Back to Immunodermatology Laboratory
09.28.11 |
